US2021076995A1PendingUtilityA1
Method and apparatus for predicting analyte concentration
Assignee: SAMSUNG ELECTRONICS CO LTDPriority: Sep 23, 2015Filed: Nov 24, 2020Published: Mar 18, 2021
Est. expirySep 23, 2035(~9.2 yrs left)· nominal 20-yr term from priority
A61B 5/7275A61B 5/7267A61B 5/1455G01N 2201/129G16H 50/20G01N 33/4833A61B 2560/0223A61B 5/1495A61B 5/14546A61B 5/72A61B 5/14532G01N 21/35A61B 5/0075
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method for predicting a concentration of an in vivo analyte includes obtaining a plurality of in vivo spectra of the in vivo analyte, determining a learning section for a concentration predicting algorithm for the analyte based on an unchanged section, during which the concentration of the analyte is not substantially changed, and a plurality of the in vivo spectra, and predicting the concentration of the in vivo analyte by using the concentration predicting algorithm based on a learned result of the learning section and an intrinsic spectrum of the in vivo analyte.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for predicting a concentration of an in vivo analyte, the method comprising:
obtaining a plurality of in vivo spectra of the in vivo analyte; determining a learning section of a concentration predicting algorithm for the in vivo analyte based on an unchanged section, during which a concentration of the in vivo analyte is not substantially changed, and the in vivo spectra; and predicting the concentration of the in vivo analyte by using the concentration predicting algorithm based on a learned result of the learning section and an intrinsic spectrum of the in vivo analyte.
2 . The method of claim 1 , wherein the in vivo analyte is at least one of glucose, urea, lactate, triglyceride, protein, cholesterol, and ethanol.
3 . The method of claim 1 , wherein,
the in vivo analyte is glucose, and the unchanged section, during which the concentration of the in vivo analyte is not substantially changed, is a fasting section.
4 . The method of claim 1 , wherein the in vivo spectrum comprise at least one of an absorption spectrum or a reflection spectrum of an infra-red ray.
5 . The method of claim 1 , wherein the in vivo spectrum comprise a dispersion spectrum of a single wavelength electromagnetic wave.
6 . The method of claim 1 , wherein the obtaining the in vivo spectra of the in vivo analyte comprises obtaining the in vivo spectra continually at a predetermined time interval.
7 . The method of claim 1 , wherein the concentration predicting algorithm comprises a net analyte signal algorithm.
8 . The method of claim 1 , wherein the determining the learning section comprises:
calculating a similarity between the in vivo spectra; determining a section having a high similarity as a similar section; and determining a section, during which the unchanged section and the similar section overlap each other, as the learning section.
9 . The method of claim 8 , wherein the calculating the similarity between the in vivo spectra comprises:
aligning baselines of at least two spectra for calculating similarities thereof among the in vivo spectra; and calculating a difference between the at least two in vivo spectra, the baselines of which are aligned.
10 . The method of claim 1 , wherein the predicting the concentration of the in vivo analyte comprises predicting the concentration of the in vivo analyte in the similar section including the learning section when a length of the learning section is longer than a predetermined section length.
11 . The method of claim 1 , wherein the predicting the concentration of the in vivo analyte comprises re-determining the learning section in the similar section when a length of the learning section is shorter than a predetermined length.
12 . The method of claim 1 , wherein the predicting the concentration of the in vivo analyte comprises displaying a message to inform a user that a concentration prediction is unavailable when a length of the learning section is shorter than a predetermined length.
13 . The method of claim 1 , wherein the in vivo analyte is included in a human body, an animal, a mammal, a non-mammal or a microorganism.Join the waitlist — get patent alerts
Track US2021076995A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.